Epidemiology, mortality and effectiveness of prophylaxis for Pneumocystis jiroveci pneumonia among rheumatic patients: a territory-wide study.
Shirley Chiu Wai ChanHo Yin ChungChak Sing LauPhilip Hei LiPublished in: Annals of clinical microbiology and antimicrobials (2021)
PJP is an uncommon but important infection among rheumatic patients, PJP prophylaxis is effective and should be considered in patients with SSc, AAV and IMM, especially those receiving glucocorticoid doses above P15.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- rheumatoid arthritis
- randomized controlled trial
- peritoneal dialysis
- systematic review
- prognostic factors
- type diabetes
- cardiovascular disease
- risk factors
- intensive care unit
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome